Skip to content

Multi-institutional study on cytoreuctive nephrectomy for unresctable or metastatic renal cell carcinoma

Multi-institutional study on cytoreuctive nephrectomy for unresctable or metastatic renal cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1040220068
Enrollment
500
Registered
2022-10-07
Start date
2022-10-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic renal cell carcinoma

Interventions

None listed

Sponsors

Kumada Naotaka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (i) Patients over 20 years old with metastatic renal cancer (ii) Inpatients and outpatients

Exclusion criteria

Exclusion criteria: (1) Patients who are deemed ineligible for participation in this study by the principal investigator or subinvestigator of the medical institution where this study is conducted (ii) Patients who have requested refusal of the research use of their information by opting out.

Design outcomes

Primary

MeasureTime frame
overall survival

Secondary

MeasureTime frame
Best overall response, progression-free survival, response rate, duration of response, safety, clinical usefulness rate Patient Factors Affecting Response to Primary Resection and Adverse Events

Contacts

Public ContactGifu Committee

Gifu University Hospital

kuma7821@gifu-u.ac.jp+81-58-230-6000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026